It has many benefits, including stimulating the release of insulin and glucagon, which can help reduce blood sugar
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials
Lixisenatide, a structurally modified derivative of exendin-4, addresses some of these limitations by offering a longer half-life of approximately 3 h, thereby permitting once-daily dosing (Leon et al., 2017)
Missed a Dose of GLP-1 Medication: By Medication Missed a dose of GLP-1 medication Mounjaro (tirzepatide): Available Strengths: 2.5mg, 5mg, 7.5mg 10mg, 12.5mg, 15mg Who manufactures Mounjaro
doi:10.1001/jamainternmed.2013.2720 Smits MM, Van Raalte DH
If the research question involves comparing distinct interventions, full biological washout is mandatory, not optional